Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humans

High Altitude Medicine and Biology

Volumn 9, Issue 3, 2008, Pages 209-216

  Basnyat, Buddha ^a,b   Hargrove, Jenny ^c   Holck, Peter S ^d   Srivastav, Soni ^b   Alekh, Kshitiz ^b   Ghimire, Laxmi V ^b   Pandey, Kaushal ^b   Griffiths, Anna ^b   Shankar, Ravi ^b   Kaul, Komal ^b   Paudyal, Asmita ^b   Stasiuk, David ^b   Basnyat, Rose ^b   Davis, Christopher ^b   Southard, Andrew ^b   Robinson, Cathleen ^b   Shandley, Thomas ^b   Johnson, Dan W ^b   Zafren, Ken ^b,e   Williams, Sarah ^e   Weiss, Eric A ^e   Farrar, Jeremy J ^f   Swenson, Erik R ^g   more..

^a NEPAL INTERNATIONAL CLINIC   (Nepal)

^b Himalayan Rescue Association   (Nepal)

^c Institute for Altitude Medicine   (United States)

^d UNIVERSITY OF HAWAII   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^g UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Altitude illness; High altitude pulmonary edema; Himalayas; Nepal

Indexed keywords

ACETAZOLAMIDE; PLACEBO;

ADULT; AGED; ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DRUG TREATMENT FAILURE; DYSPEPSIA; FEMALE; HUMAN; HUMAN EXPERIMENT; LUNG ARTERY PRESSURE; LUNG EDEMA; MALE; METALLIC LIKE TASTE; MORBIDITY; MOUNTAINEERING; NEPAL; NORMAL HUMAN; OXYGEN SATURATION; PARESTHESIA; POLYURIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SYSTOLIC BLOOD PRESSURE; TASTE DISORDER; TRICUSPID VALVE REGURGITATION;

ACETAZOLAMIDE; ADULT; ALTITUDE SICKNESS; BLOOD PRESSURE; CARBONIC ANHYDRASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MOUNTAINEERING; NEPAL; PULMONARY ARTERY; PULMONARY EDEMA; PULMONARY WEDGE PRESSURE;

EID: 52449132949     PISSN: 15270297     EISSN: None     Source Type: Journal    
DOI: 10.1089/ham.2007.1073     Document Type: Article

References (30)

1. Allemann Y., Sartori C., Lepori M., Pierre S., Melot C., Naeije R., Scherrer U., and Maggiorini M. (2000). Echocardiographic and invasive measurements of pulmonary artery pressure correlate closely at high altitude. Am. J. Physiol. Heart Circ. Physiol. 279:H2013-H2016.
2. Bartsch P., Maggiorini M., Ritter M., Noti C., Vock P., and Oelz O.(1991). Prevention of high altitude pulmonary edema by nifedipine. N. Engl. J. Med. 325:1284-1289.
3. Bartsch P., Mairbaurl H., Magiorinni M., and Swenson E.R. (2005). Physiological aspects of high altitude pulmonary edema. J. Appl. Physiol. 98:1101-1110.
4. Basnyat B., Gertsch J.H., Johnson E.W., Castro-Marine E., Inoue Y., and Yeh C. (2003). Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: A prospective, double-blind, randomized, placebo-controlled trial. High Alt. Med. Biol. 4:45-52.
5. Basnyat B., Gertsch J.H., Holck P.S., Johnson E.W., Luks A.M., Donham B.P., Fleischman R.J., Gowder D.W., Hawksworth J.S., Jensen B.T., Kleiman R.J., Loveridge A.H., Lundeen E.B., Newman S.L., Noboa J.A., Miegs D.P., O'Beirne K.A., Philpot K.B., Schultz M.N., Valente M.C., Wiebers M.R., and Swenson E.R. (2006). Acetazolamide 125 mg bid is not significantly different from 375 mg bid in the prevention of acute mountain sickness. High Alt. Med. Biol. 7:17-27.
6. Basnyat B., and Murdoch D. (2003). High altitude illness: An update of pathophysiology, prevention, and treatment. Lancet 361:1967-1974
7. Berg J.T., Ramanathan S., and Swenson E.R. (2004). Inhibitors of hypoxic pulmonary vasoconstriction prevent high-altitude pulmonary edema in rats. Wild. Environ. Med. 15:32-37.
8. Cremona G., Asnaghi R., Baderna P., Brunetto A., Brutsaert T., Cavallaro C., Clark T.M., Cogo A., Donis R., Lanfranchi P., Luks A., Novello N., Panzetta S., Perini L., Putnam M., Spagnolatti L., Wagner H., and Wagner P.D. (2002). Pulmonary extravascular fluid accumulation in recreational climbers: A prospective study. Lancet 359:303-309.
9. Deem S., Hedges R.G., Kerr M.E., and Swenson E.R.(2000). Acetazolamide reduces hypoxic pulmonary vasoconstriction in isolated perfused rabbit lungs. Respir. Physiol. 123:109-119.
10. Durmowicz A.G., Noordeweir E., Nicholas R., and Reeves J.T. (1997) Inflammatory process may predispose children to high altitude pulmonary edema. J. Pediatr. 130:838-840
11. Faoro V., Huez S., Giltaire S., Pavelescu A., Van Osta A., Moraine J.J., Guenard H., Martinot J.B., and Naeije R. (2007). Effects of Acetazolamide on aerobic exercise capacity and pulmonary hemodynamics at high altitude. J. Appl. Physiol. 103:1161-1165.
12. Gertsch J.H., Basnyat B., Johnson E.W., Onopa J., and Holck P.S. (2004). Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). BMJ 328:797-799.
13. Hackett P.H. and Rennie D. (1976). The incidence, importance, and prophylaxis of acute mountain mountain sickness. Lancet 2:1149-1155.
14. Hohne C., Krebs M.O., Seiferheld M., Boemke W., Kaczmarczyk G., and Swenson E.R. (2004). Acetazolamide prevents hypoxic pulmonary vasoconstriction in conscious dogs. J. Appl. Physiol. 97:515-521.
15. Hohen C., Pickerodt P.A., Francis R.C., Boemke W., and Swenson E.R. (2007). Pulmonary vasodilation by acetazolamide during hypoxia is unrelated to carbonic anhydrase inhibition. Am. J. Physiol. Lung Cell. Mol. Physiol. 292:L178-L184.
16. Maggiorini M., Brunner-La Rocca H.P., Peth S., Fischler M., Böhm T., Bernheim A., Kiencke S., Bloch K.E., Dehnert C., Naeije R., Lehmann T., Bärtsch P., and Mairbäurl H. (2006). Both tadalafil and dexamethasone may reduce the incidence of high altitude pulmonary edema. Ann. Intern. Med. 145:497-506.
17. Morrell N.W., Nijran K.S., Biggs T., and Seed W.A. (1995). Magnitude and time course of acute hypoxic pulmonary vasoconstriction in man. Respir. Physiol. 100:271-281.
18. Meyrick B., and Reid L. (1980). Hypoxia-induced structural changes in the media and adventitia of the rat hilar pulmonary artery and their regression. Am. J. Pathol. 100:151-178.
19. Roach R.C., Bartch P., Hackett P.H., and Oelz O. (1993). Lake Louise Acute Mountain Sickness Scoring System. In: Hypoxia and Molecular Medicine, J.R. Sutton, G. Coates, and G.H. Houston, eds. Burlington, VT: Queen City Press, pp. 272-274.
20. R Development Core Team (2007). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org
21. Sartori C., Allemann Y., Duplain H., Lepori M., Egli M., Lipp E., Hutter D., Turini P., Hugli O., Cook S., Nicod P., and Scherrer U. (2002). Salmeterol for the prevention of high altitude pulmonary edema. N. Engl. J. Med. 346:1631-1636.
22. Shimoda L.A., Luke T., Sylvester J.T., Shih H.W., Jain A., and Swenson E.R. (2007). Inhibition of hypoxia-induced calcium responses in pulmonary arterial smooth muscle by acetazolamide is independent of carbonic anhydrase inhibition. Am. J. Physiol. Lung Cell. Mol. Physiol. 292:L1002-L1012.
23. Stenmark K.R., Frid M., Nemenoff R., Dempsey E.C., and Das M. (1999). Hypoxia induces cell - specific changes in gene expression in vascular wall cells: implications for pulmonary hypertension. In: Hypoxia: Into the Next Millennium, Vol. 474, Advances in Experimental Medicine and Biology, R.C. Roach, P.D. Wagner, and P.H. Hackett, eds. New York: Kluwer Academic/Plenum, pp. 231-258.
24. Swenson E.R. (1998). Carbonic anhydrase inhibitors and ventilation: A complex interplay of stimulation and suppression. Eur. Respir. J. 12:1242-1247.
25. Swenson E.R. (2006). Carbonic anhydrase inhibitors and hypoxic pulmonary vasoconstriction. Respir. Physiol. Neurobiol. 151:209-216.
26. Swenson E.R, and Teppema L.J. (2007). Prevention of acute mountain sickness by acetazolamide: As yet an unfinished story. J. Appl. Physiol.102:1305-1307.
27. Swenson E.R., Maggiorini M., Mongovin S., et al.(2002). Pathogenesis of high-altitude pulmonary edema: Inflammation is not an etiologic factor. JAMA 287:2228-2235.
28. Tozzi C.A., Poiani G.J., Harangozo A.M., Boyd C.D., and Riley D.J. (1989). Pressure-induced connective tissue synthesis in pulmonary artery segments is dependent on intact endothelium. J. Clin. Invest. 84:1005-1012.
29. Talbot N.P., Balanos G.M., Dorrington K.L., and Robbins P.A. (2005). Two temporal components within the human pulmonary vascular response to approximately 2 h of isocapnic hypoxia. J. Appl. Physiol. 98:1125-1139.
30. Teppema L.J., Balanos G.M., Steinback C.D., Brown A.D., Foster G.E., Duff H.J., Leigh R., and Poulin M.J. (2007). Effects of acetazolamide on ventilatory, cerebrovascular, and pulmonary vascular responses to hypoxia. Am. J. Respir. Crit. Care Med. 75:277-281.